MLYS

Conviction 38HealthcareScan · Mon, Aug 10, 2026

MLYS$27.38+0.09%

ResistanceSupportVol 14Insider sell

Vol MA14 735.44K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Mineralys Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSmineralystx.com ↗

Price27.38

Change+0.09%

Gap+0.62%

Rel volume3.46×

Avg volume687.62K

Avg $ vol18.47M

SMA 2026.84

SMA 5026.62

SMA 20031.03

Price vs 50+2.85%

Price vs 200-11.79%

MA stackmixed

50/200 cross—

Supertrenddown · 29.28

RSI (14)54

MACD hist0.06

MACD crossbull · 1d

Stoch %K / %D75 / 71

ADX (14)10

+DI / −DI24 / 16

RSI divergence—

MACD divergence—

ATR %+4.34%

ADR %3.97%

52w high47.33

52w low13.00

From 52w high-42.16%

Above 52w low+110.58%

New 52w highNo

SqueezeOn · 4d

Bollinger width7.78%

%B0.76

Donchian pos74.88%

Donchian high28.19

Donchian low24.95

AVWAP (52w high)30.44

vs AVWAP high-10.06%

AVWAP (52w low)31.43

vs AVWAP low-12.89%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d3.46×

Avg vol (14d)735.44K

Avg vol (20d)687.62K

Avg $ vol (20d)18.47M

Market cap—

RS 3m (vs SPY)-12.51%

RS 6m (vs SPY)-17.16%

RS line new highNo

Trend template2/8

Technical rank31.8

1 week+6.19%

1 month-3.54%

3 months-7.33%

6 months-8.05%

1 year+112.70%

YTD-23.34%

P/E-14.58

P/B3.53

P/S—

P/FCF-15.84

EPS-2.29

Div yield—

ROE-24.23%

ROA-23.69%

Debt/Eq—

Current44.33

EV/EBITDA-12.56

Gross margin—

Net margin—

Rev growth—

EPS growth13.02%

Price target50.00

Target upside82.88%

Analyst ratingBuy

Institutional110.21%

Ent. value2.14B

Revenue—

Net income-39.34M

Gross profit—

Free cash flow-142.43M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out82.5M

Employees76

ListedFri, Feb 10, 2023

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction38 / 100

Pattern quality—

Tech rank31.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance29.65

Support25.19

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MLYS

All disclosures →

No recent disclosed trades by Congress in MLYS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MLYS · 4 buys · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-07-15	Sell	6.35K	$169K	2026-07-15	2026-07-15
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-07-13	Exercise	3.54K	$36K	2026-07-13	2026-07-15
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-07-13	Exercise	4.17K	$59K	2026-07-13	2026-07-15
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-07-13	Exercise	6.35K	$7K	2026-07-13	2026-07-15
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-07-13	Sell	14.06K	$388K	2026-07-13	2026-07-15
Rodman David Malcom Chief Medical Officer · Stock Option · 2026-07-13	Exercise	3.54K	—	2026-07-13	2026-07-15
Rodman David Malcom Chief Medical Officer · Stock Option · 2026-07-13	Exercise	4.17K	—	2026-07-13	2026-07-15
Rodman David Malcom Chief Medical Officer · Stock Option · 2026-07-13	Exercise	6.35K	—	2026-07-13	2026-07-15
Congleton Jon Chief Executive Officer · Common Stock · 2026-07-13	Sell	10.7K	$291K	2026-07-13	2026-07-15
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-07-09	Exercise	2.17K	$35K	2026-07-09	2026-07-10

SEC filings

EDGAR filings in MLYS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.